GSC-DCV
1 product
1 abstract
Abstract
Phase IIb randomized, blinded, controlled trial evaluating neoadjuvant PD-1 blockade combined with A2B5+ glioma stem-like cell lysate-loaded DC vaccine in recurrent glioblastoma (IDH1/2 -).Org: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China, Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shang Hai, China, Shanghai Medsyin Biopharma Co., Ltd., Shang Hai, China, St. John's Cancer Institute, Santa Monica, CA, Shanghai Clinical Medical Center of Neurosurgery, Shanghai, China,
Product
aPD-1 mAbs and GSC-DCV